Clinical Trials Browser

Has results × Meningioma × pembrolizumab × Clear all

NCT03279692 2026-01-29

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

Phase 2 Active not recruiting

26 enrolled 14 charts

Meningioma

NCT03016091 2025-02-18

A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma

Phase 2 Terminated

18 enrolled 9 charts

Hemangiopericytoma, Meningioma